Secondary sphere formation enhances the functionality of cardiac progenitor cells

Hyun Jai Cho, Ho Jae Lee, Seock Won Youn, Seok Jin Koh, Joo Yun Won, Yeon Ju Chung, Hyun Ju Cho, Chang Hwan Yoon, Sae Won Lee, Eun Ju Lee, Yoo Wook Kwon, Hae Young Lee, Sang Hun Lee, Won Kyung Ho, Young Bae Park, Hyo Soo Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Loss of cardiomyocytes impairs cardiac function after myocardial infarction (MI). Recent studies suggest that cardiac stem/progenitor cells could repair the damaged heart. However, cardiac progenitor cells are difficult to maintain in terms of purity and multipotency when propagated in two-dimensional culture systems. Here, we investigated a new strategy that enhances potency and enriches progenitor cells. We applied the repeated sphere formation strategy (cardiac explant → primary cardiosphere (CS) formation → sphere-derived cells (SDCs) in adherent culture condition → secondary CS formation by three-dimensional culture). Cells in secondary CS showed higher differentiation potentials than SDCs. When transplanted into the infarcted myocardium, secondary CSs engrafted robustly, improved left ventricular (LV) dysfunction, and reduced infarct sizes more than SDCs did. In addition to the cardiovascular differentiation of transplanted secondary CSs, robust vascular endothelial growth factor (VEGF) synthesis and secretion enhanced neovascularization in the infarcted myocardium. Microarray pathway analysis and blocking experiments using E-selectin knock-out hearts, specific chemicals, and small interfering RNAs (siRNAs) for each pathway revealed that E-selectin was indispensable to sphere initiation and ERK/Sp1/VEGF autoparacrine loop was responsible for sphere maturation. These results provide a simple strategy for enhancing cellular potency for cardiac repair. Furthermore, this strategy may be implemented to other types of stem/progenitor cell-based therapy.

Original languageEnglish (US)
Pages (from-to)1750-1766
Number of pages17
JournalMolecular Therapy
Volume20
Issue number9
DOIs
StatePublished - Jan 1 2012

Fingerprint

Stem Cells
E-Selectin
Vascular Endothelial Growth Factor A
Myocardium
Left Ventricular Dysfunction
Microarray Analysis
Cell- and Tissue-Based Therapy
Cardiac Myocytes
Small Interfering RNA
Myocardial Infarction

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

Cho, H. J., Lee, H. J., Youn, S. W., Koh, S. J., Won, J. Y., Chung, Y. J., ... Kim, H. S. (2012). Secondary sphere formation enhances the functionality of cardiac progenitor cells. Molecular Therapy, 20(9), 1750-1766. https://doi.org/10.1038/mt.2012.109

Secondary sphere formation enhances the functionality of cardiac progenitor cells. / Cho, Hyun Jai; Lee, Ho Jae; Youn, Seock Won; Koh, Seok Jin; Won, Joo Yun; Chung, Yeon Ju; Cho, Hyun Ju; Yoon, Chang Hwan; Lee, Sae Won; Lee, Eun Ju; Kwon, Yoo Wook; Lee, Hae Young; Lee, Sang Hun; Ho, Won Kyung; Park, Young Bae; Kim, Hyo Soo.

In: Molecular Therapy, Vol. 20, No. 9, 01.01.2012, p. 1750-1766.

Research output: Contribution to journalArticle

Cho, HJ, Lee, HJ, Youn, SW, Koh, SJ, Won, JY, Chung, YJ, Cho, HJ, Yoon, CH, Lee, SW, Lee, EJ, Kwon, YW, Lee, HY, Lee, SH, Ho, WK, Park, YB & Kim, HS 2012, 'Secondary sphere formation enhances the functionality of cardiac progenitor cells', Molecular Therapy, vol. 20, no. 9, pp. 1750-1766. https://doi.org/10.1038/mt.2012.109
Cho HJ, Lee HJ, Youn SW, Koh SJ, Won JY, Chung YJ et al. Secondary sphere formation enhances the functionality of cardiac progenitor cells. Molecular Therapy. 2012 Jan 1;20(9):1750-1766. https://doi.org/10.1038/mt.2012.109
Cho, Hyun Jai ; Lee, Ho Jae ; Youn, Seock Won ; Koh, Seok Jin ; Won, Joo Yun ; Chung, Yeon Ju ; Cho, Hyun Ju ; Yoon, Chang Hwan ; Lee, Sae Won ; Lee, Eun Ju ; Kwon, Yoo Wook ; Lee, Hae Young ; Lee, Sang Hun ; Ho, Won Kyung ; Park, Young Bae ; Kim, Hyo Soo. / Secondary sphere formation enhances the functionality of cardiac progenitor cells. In: Molecular Therapy. 2012 ; Vol. 20, No. 9. pp. 1750-1766.
@article{ae33e04e41e447aea0b5482ef73db17d,
title = "Secondary sphere formation enhances the functionality of cardiac progenitor cells",
abstract = "Loss of cardiomyocytes impairs cardiac function after myocardial infarction (MI). Recent studies suggest that cardiac stem/progenitor cells could repair the damaged heart. However, cardiac progenitor cells are difficult to maintain in terms of purity and multipotency when propagated in two-dimensional culture systems. Here, we investigated a new strategy that enhances potency and enriches progenitor cells. We applied the repeated sphere formation strategy (cardiac explant → primary cardiosphere (CS) formation → sphere-derived cells (SDCs) in adherent culture condition → secondary CS formation by three-dimensional culture). Cells in secondary CS showed higher differentiation potentials than SDCs. When transplanted into the infarcted myocardium, secondary CSs engrafted robustly, improved left ventricular (LV) dysfunction, and reduced infarct sizes more than SDCs did. In addition to the cardiovascular differentiation of transplanted secondary CSs, robust vascular endothelial growth factor (VEGF) synthesis and secretion enhanced neovascularization in the infarcted myocardium. Microarray pathway analysis and blocking experiments using E-selectin knock-out hearts, specific chemicals, and small interfering RNAs (siRNAs) for each pathway revealed that E-selectin was indispensable to sphere initiation and ERK/Sp1/VEGF autoparacrine loop was responsible for sphere maturation. These results provide a simple strategy for enhancing cellular potency for cardiac repair. Furthermore, this strategy may be implemented to other types of stem/progenitor cell-based therapy.",
author = "Cho, {Hyun Jai} and Lee, {Ho Jae} and Youn, {Seock Won} and Koh, {Seok Jin} and Won, {Joo Yun} and Chung, {Yeon Ju} and Cho, {Hyun Ju} and Yoon, {Chang Hwan} and Lee, {Sae Won} and Lee, {Eun Ju} and Kwon, {Yoo Wook} and Lee, {Hae Young} and Lee, {Sang Hun} and Ho, {Won Kyung} and Park, {Young Bae} and Kim, {Hyo Soo}",
year = "2012",
month = "1",
day = "1",
doi = "10.1038/mt.2012.109",
language = "English (US)",
volume = "20",
pages = "1750--1766",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Secondary sphere formation enhances the functionality of cardiac progenitor cells

AU - Cho, Hyun Jai

AU - Lee, Ho Jae

AU - Youn, Seock Won

AU - Koh, Seok Jin

AU - Won, Joo Yun

AU - Chung, Yeon Ju

AU - Cho, Hyun Ju

AU - Yoon, Chang Hwan

AU - Lee, Sae Won

AU - Lee, Eun Ju

AU - Kwon, Yoo Wook

AU - Lee, Hae Young

AU - Lee, Sang Hun

AU - Ho, Won Kyung

AU - Park, Young Bae

AU - Kim, Hyo Soo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Loss of cardiomyocytes impairs cardiac function after myocardial infarction (MI). Recent studies suggest that cardiac stem/progenitor cells could repair the damaged heart. However, cardiac progenitor cells are difficult to maintain in terms of purity and multipotency when propagated in two-dimensional culture systems. Here, we investigated a new strategy that enhances potency and enriches progenitor cells. We applied the repeated sphere formation strategy (cardiac explant → primary cardiosphere (CS) formation → sphere-derived cells (SDCs) in adherent culture condition → secondary CS formation by three-dimensional culture). Cells in secondary CS showed higher differentiation potentials than SDCs. When transplanted into the infarcted myocardium, secondary CSs engrafted robustly, improved left ventricular (LV) dysfunction, and reduced infarct sizes more than SDCs did. In addition to the cardiovascular differentiation of transplanted secondary CSs, robust vascular endothelial growth factor (VEGF) synthesis and secretion enhanced neovascularization in the infarcted myocardium. Microarray pathway analysis and blocking experiments using E-selectin knock-out hearts, specific chemicals, and small interfering RNAs (siRNAs) for each pathway revealed that E-selectin was indispensable to sphere initiation and ERK/Sp1/VEGF autoparacrine loop was responsible for sphere maturation. These results provide a simple strategy for enhancing cellular potency for cardiac repair. Furthermore, this strategy may be implemented to other types of stem/progenitor cell-based therapy.

AB - Loss of cardiomyocytes impairs cardiac function after myocardial infarction (MI). Recent studies suggest that cardiac stem/progenitor cells could repair the damaged heart. However, cardiac progenitor cells are difficult to maintain in terms of purity and multipotency when propagated in two-dimensional culture systems. Here, we investigated a new strategy that enhances potency and enriches progenitor cells. We applied the repeated sphere formation strategy (cardiac explant → primary cardiosphere (CS) formation → sphere-derived cells (SDCs) in adherent culture condition → secondary CS formation by three-dimensional culture). Cells in secondary CS showed higher differentiation potentials than SDCs. When transplanted into the infarcted myocardium, secondary CSs engrafted robustly, improved left ventricular (LV) dysfunction, and reduced infarct sizes more than SDCs did. In addition to the cardiovascular differentiation of transplanted secondary CSs, robust vascular endothelial growth factor (VEGF) synthesis and secretion enhanced neovascularization in the infarcted myocardium. Microarray pathway analysis and blocking experiments using E-selectin knock-out hearts, specific chemicals, and small interfering RNAs (siRNAs) for each pathway revealed that E-selectin was indispensable to sphere initiation and ERK/Sp1/VEGF autoparacrine loop was responsible for sphere maturation. These results provide a simple strategy for enhancing cellular potency for cardiac repair. Furthermore, this strategy may be implemented to other types of stem/progenitor cell-based therapy.

UR - http://www.scopus.com/inward/record.url?scp=84867040569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867040569&partnerID=8YFLogxK

U2 - 10.1038/mt.2012.109

DO - 10.1038/mt.2012.109

M3 - Article

VL - 20

SP - 1750

EP - 1766

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 9

ER -